List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 24 studies with search of: "Chiesi Farmaceutici S.p.A." [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms
Condition: Bronchial Asthma
Interventions: Drug: Beclomethasone dipropionate;   Drug: Beclomethasone dipropionate/Salbutamol combination;   Drug: Salbutamol
2 Completed Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-Week Treatment Period of Adult Patients With Uncontrolled Asthma
Condition: Bronchial Asthma
Interventions: Drug: salbutamol 100 mcg;   Drug: BDP/salbutamol HFA pMDI;   Drug: BDP/salbutamol CFC pMDI
3 Active, not recruiting Next DPI LABA, Multicentre, 5-Way Cross-Over, Adult Asthmatic Patients
Condition: Asthma
Interventions: Drug: CHF 1535 Next DPI;   Drug: Foster BDP/Formoterol;   Drug: Placebo
4 Recruiting A 48-week Study Comparing the Efficacy of Foster for Maintenance and Reliever Versus Foster for Maintenance + Salbutamol as Reliever in Asthmatics
Condition: Asthma
Interventions: Drug: Foster;   Drug: Ventolin
5 Recruiting Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
Condition: Asthma
Interventions: Drug: Beclomethasone plus formoterol fixed combination;   Drug: Fluticasone plus salmeterol fixed combination
6 Completed Formoterol-HFA 3-month Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Formoterol
7 Completed Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Formoterol;   Drug: Placebo
8 Not yet recruiting BDP/FF (Beclomethasone Dipropionate) Versus Formoterol Fumarate (FF) in Patients With Severe Chronic Obstructive Pulmonary Disease
Condition: Severe Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: CHF1535;   Drug: Formoterol fumarate
9 Not yet recruiting Efficacy of Nebulized Beclomethasone Dipropionate (BDP) in the Treatment of Moderate Croup
Condition: Croup
Interventions: Drug: beclomethasone dipropionate suspension for nebulisation 800 mcg/2 ml;   Drug: Placebo solution for nebulisation 2 ml
10 Completed Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma
Condition: Asthma
Intervention: Drug: Fixed combination Beclomethasone Dipropionate/Formoterol HFA 134a-pMDI
11 Recruiting A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
Condition: Cystic Fibrosis
Intervention: Drug: tobramycin
12 Completed EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI
Condition: Bronchial Asthma
Interventions: Drug: beclomethasone dipropionate plus formoterol fumarate combination;   Drug: fluticasone propionate plus salmeterol xinafoate combination
13 Completed Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma
Condition: Asthma
Intervention: Drug: Fixed combination Beclomethasone/formoterol HFA 134a-pMDI
14 Active, not recruiting FACTO Study (Foster® As Complete Treatment Option)
Condition: Asthmatic Patients
Interventions: Drug: FOSTER;   Drug: Seretide
15 Completed Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study
Condition: Respiratory Distress Syndrome, Newborn
Intervention: Drug: Poractant alfa (Curosurf®)
16 Completed Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI in Patients With COPD
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: carmoterol;   Drug: placebo;   Drug: salmeterol
17 Completed Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
Condition: Bronchial Asthma
Interventions: Drug: beclomethasone dipropionate plus formoterol fumarate combination;   Drug: budesonide plus formoterol combination
18 Completed As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma
Condition: Asthma
Interventions: Drug: beclomethasone/salbutamol combination;   Drug: beclomethasone;   Drug: salbutamol
19 Completed Dose Finding Study of CHF 4226 for Treating Patients With COPD
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: carmoterol;   Drug: salmeterol;   Drug: placebo
20 Active, not recruiting A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma
Condition: Asthma
Interventions: Drug: BDP/Formoterol Next DPI;   Drug: Foster

Previous Page Studies Shown (1-20) Next Page (21-24)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services